BNT162b2 against COVID-19 in Brazil using a test-negative design: Study protocol and statistical analysis plan.
Saved in:
| Title: | BNT162b2 against COVID-19 in Brazil using a test-negative design: Study protocol and statistical analysis plan. |
|---|---|
| Authors: | Goulart Rosa R; Social Responsibility Unit, Hospital Moinhos de Vento (HMV), Porto Alegre, RS, Brazil.; Research Unit, Inova Medical, Porto Alegre, RS, Brazil., Spinardi J; Pfizer, Vaccines Medical and Scientific Affairs-Emerging Markets, Collegeville, PA, United States of America., Allen KE; Pfizer, Vaccines Medical and Scientific Affairs-Emerging Markets, Collegeville, PA, United States of America., Manfio J; Research Institute, HMV, Porto Alegre, RS, Brazil., de Araujo CLP; Research Institute, HMV, Porto Alegre, RS, Brazil., Cohen M; Research Institute, HMV, Porto Alegre, RS, Brazil., Robinson CC; Research Unit, Inova Medical, Porto Alegre, RS, Brazil., Sganzerla D; Unimed, Porto Alegre, RS, Brazil., Ferreira D; Otus Solutions, Porto Alegre, RS, Brazil., de Souza EM; Universidade Federal do Paraná (UFPR), Curitiba, PR, Brazil., de Oliveira JC; Universidade Federal do Paraná (UFPR), Curitiba, PR, Brazil., Gradia DF; Universidade Federal do Paraná (UFPR), Curitiba, PR, Brazil., Brandalize APC; Universidade Federal do Paraná (UFPR), Curitiba, PR, Brazil., Kucharski GA; Secretaria Municipal de Saúde de Toledo, Toledo, PR, Brazil., Pedrotti F; Secretaria Municipal de Saúde de Toledo, Toledo, PR, Brazil., Rodrigues CO; Universidade Federal do Paraná (UFPR), Curitiba, PR, Brazil., Kyaw MH; Pfizer, Vaccines Medical and Scientific Affairs-Emerging Markets, Collegeville, PA, United States of America., Castillo GDCM; Pfizer, Vaccines Medical and Scientific Affairs-Emerging Markets, Collegeville, PA, United States of America., Srivastava A; Pfizer, Vaccines Medical and Scientific Affairs-Emerging Markets, Collegeville, PA, United States of America., McLaughlin JM; Pfizer, Vaccines Medical and Scientific Affairs-Emerging Markets, Collegeville, PA, United States of America., Falavigna M; Social Responsibility Unit, Hospital Moinhos de Vento (HMV), Porto Alegre, RS, Brazil.; Research Unit, Inova Medical, Porto Alegre, RS, Brazil.; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada. |
| Source: | PloS one [PLoS One] 2022 Oct 20; Vol. 17 (10), pp. e0276384. Date of Electronic Publication: 2022 Oct 20 (Print Publication: 2022). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Clinical Trial Protocol |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1932-6203 |
|---|---|
| DOI: | 10.1371/journal.pone.0276384 |
